KITE

Kite Pharma, Inc.

No insider bought or sold Kite Pharma, Inc. in the last 12 months

$0Bought, 12 mo

$0Sold, 12 mo

Follow KITE

KITE over the last year

Prices for KITE aren't in yet.

KITE after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

85 insider filings since 2016, newest first

KITESell

Shawn Tomasello · Chief Commercial Officer

$249K−9.0%Dec 22

KITESell

Helen Susan Kim · EVP, Business Development

$48K−10.0%Dec 22

KITESell

David D Chang · EVP, R, D, Chief Medical Offic

$91K−7.0%Dec 22

KITESell

Arie Belldegrun · Chair, President and CEO

$178KDec 22

KITESell

Jeffrey Wiezorek · SVP Clinical Development

$76K−5.0%Dec 5

KITESell

Cynthia M Butitta · COO

$504K−9.0%Nov 29

KITESell

Cynthia M Butitta · COO

$506K−9.0%Nov 14

KITESell

Jeffrey Wiezorek · SVP Clinical Development

$75K−9.0%Nov 14

KITESell

Jeffrey Wiezorek · SVP Clinical Development

$82K−9.0%Oct 5

KITESell

Cynthia M Butitta · COO

$541K−9.0%Sep 28

KITESell

Jeffrey Wiezorek · SVP Clinical Development

$87K−9.0%Sep 2

KITESell

Cynthia M Butitta · COO

$583K−9.0%Aug 26

KITESell

Helen Susan Kim · EVP, Business Development

$2.2M−80.0%Aug 16

KITESell

Jeffrey Wiezorek · SVP Clinical Development

$85K−9.0%Aug 2

KITESell

Cynthia M Butitta · COO

$509K−9.0%Jul 26

KITESell

Jeffrey Wiezorek · SVP Clinical Development

$75K−9.0%Jul 5

KITESell

Cynthia M Butitta · COO

$1.0M−17.0%Jun 27

KITESell

Roy Doumani · Director

$813K−8.0%Jun 8

KITESell

Jeffrey Wiezorek · SVP Clinical Development

$152K−17.0%Jun 2

KITESell

Cynthia M Butitta · COO and CFO

$500K−9.0%Apr 6

KITESell

Jeffrey Wiezorek · SVP Clinical Development

$404K−38.0%Mar 17

KITESell

Rizwana F Sproule · VP Regulatory Affairs

$385K−45.0%Mar 17

KITESell

Margo R Roberts · Chief Scientific Officer

$385K−44.0%Mar 17

KITESell

Cynthia M Butitta · COO and CFO

$500K−9.0%Mar 3

KITESell

Margo R Roberts · Chief Scientific Officer

$434K−51.0%Feb 19

KITESell

Rizwana F Sproule · VP Regulatory Affairs

$431K−52.0%Feb 19

KITESell

Jeffrey Wiezorek · SVP Clinical Development

$397K−40.0%Feb 18

KITESell

Margo R Roberts · Chief Scientific Officer

$1.2M−67.0%Feb 16

KITESell

Cynthia M Butitta · COO and CFO

$95K−2.0%Feb 4

KITESell

Marc Better · VP, Product Sciences

$426K−54.0%Feb 3

KITESell

Cynthia M Butitta · COO and CFO

$418K−8.0%Jan 29

KITESell

Jeffrey Wiezorek · SVP Clinical Development

$497K−40.0%Jan 19

KITESell

Rizwana F Sproule · VP Regulatory Affairs

$531K−52.0%Jan 19

KITESell

Margo R Roberts · Chief Scientific Officer

$339K−40.0%Jan 19

KITESell

Marc Better · VP, Product Sciences

$554K−54.0%Jan 5

Newer filings

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.